• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用多种CRISPR-Cas系统的正交转录调控和基因编辑

Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems.

作者信息

Broksø Amalie Dyrelund, Bendixen Louise, Fammé Simon, Mikkelsen Kasper, Jensen Trine Ilsø, Bak Rasmus O

机构信息

Department of Biomedicine, Aarhus University, Aarhus C, Denmark.

Department of Biomedicine, Aarhus University, Aarhus C, Denmark.

出版信息

Mol Ther. 2025 Jan 8;33(1):71-89. doi: 10.1016/j.ymthe.2024.11.024. Epub 2024 Nov 19.

DOI:10.1016/j.ymthe.2024.11.024
PMID:39563029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11764084/
Abstract

CRISPR-Cas-based transcriptional activation (CRISPRa) and interference (CRISPRi) enable transient programmable gene regulation by recruitment or fusion of transcriptional regulators to nuclease-deficient Cas (dCas). Here, we expand on the emerging area of transcriptional engineering and RNA delivery by benchmarking combinations of RNA-delivered dCas and transcriptional modulators. We utilize dCas9 from Staphylococcus aureus and Streptococcus pyogenes for orthogonal transcriptional modulation to upregulate one set of genes while downregulating another. We also establish trimodal genetic engineering by combining orthogonal transcriptional regulation with gene knockout by Cas12a (Acidaminococcus; AsCas12a) ribonucleoprotein delivery. To simplify trimodal engineering, we explore optimal parameters for implementing truncated single guide RNAs (sgRNAs) to make use of SpCas9 for knockout and CRISPRa. We find the Cas9 protein/sgRNA ratio to be crucial for avoiding sgRNA cross-complexation and for balancing knockout and activation efficiencies. We demonstrate high efficiencies of trimodal genetic engineering in primary human T cells while preserving basic T cell health and functionality. This study highlights the versatility and potential of complex genetic engineering using multiple CRISPR-Cas systems in a simple one-step process yielding transient transcriptome modulation and permanent DNA changes. We believe such elaborate engineering can be implemented in regenerative medicine and therapies to facilitate more sophisticated treatments.

摘要

基于CRISPR-Cas的转录激活(CRISPRa)和干扰(CRISPRi)通过将转录调节因子招募或融合到核酸酶缺陷型Cas(dCas)来实现瞬时可编程基因调控。在此,我们通过对RNA递送的dCas和转录调节剂的组合进行基准测试,拓展了转录工程和RNA递送这一新兴领域。我们利用来自金黄色葡萄球菌和化脓性链球菌的dCas9进行正交转录调控,以上调一组基因同时下调另一组基因。我们还通过将正交转录调控与Cas12a(嗜氨基酸球菌;AsCas12a)核糖核蛋白递送介导的基因敲除相结合,建立了三模态基因工程。为了简化三模态工程,我们探索了实施截短的单向导RNA(sgRNA)以利用SpCas9进行敲除和CRISPRa的最佳参数。我们发现Cas9蛋白与sgRNA的比例对于避免sgRNA交叉复合以及平衡敲除和激活效率至关重要。我们在原代人T细胞中展示了三模态基因工程的高效性,同时保留了基本的T细胞健康和功能。这项研究突出了在一个简单的一步过程中使用多种CRISPR-Cas系统进行复杂基因工程的多功能性和潜力,该过程可产生瞬时转录组调节和永久性DNA改变。我们相信这种精细的工程可应用于再生医学和治疗中,以促进更复杂的治疗。

相似文献

1
Orthogonal transcriptional modulation and gene editing using multiple CRISPR-Cas systems.使用多种CRISPR-Cas系统的正交转录调控和基因编辑
Mol Ther. 2025 Jan 8;33(1):71-89. doi: 10.1016/j.ymthe.2024.11.024. Epub 2024 Nov 19.
2
[Improving the Efficiency and Safety of Human CCR5 Gene Editing by Selection of Optimal Guide RNAs for SpCAS9 and CAS12A].通过为SpCAS9和CAS12A选择最佳引导RNA提高人类CCR5基因编辑的效率和安全性
Mol Biol (Mosk). 2025 Mar-Apr;59(2):234-243.
3
Structural basis of a dual-function type II-B CRISPR-Cas9.双功能II-B型CRISPR-Cas9的结构基础
Nucleic Acids Res. 2025 Jun 20;53(12). doi: 10.1093/nar/gkaf585.
4
Focused ultrasound and microbubble-mediated delivery of CRISPR-Cas9 ribonucleoprotein to human induced pluripotent stem cells.聚焦超声与微泡介导的CRISPR-Cas9核糖核蛋白向人诱导多能干细胞的递送
Mol Ther. 2025 Mar 5;33(3):986-996. doi: 10.1016/j.ymthe.2025.01.013. Epub 2025 Jan 10.
5
Harnessing an anti-CRISPR protein for powering CRISPR/Cas9-mediated genome editing in undomesticated Bacillus strains.利用一种抗CRISPR蛋白在未驯化的芽孢杆菌菌株中推动CRISPR/Cas9介导的基因组编辑。
Microb Cell Fact. 2025 Jun 23;24(1):143. doi: 10.1186/s12934-025-02776-z.
6
Visualization of a multi-turnover Cas9 after product release.产物释放后多轮循环Cas9的可视化。
Nat Commun. 2025 Jul 1;16(1):5681. doi: 10.1038/s41467-025-60668-7.
7
Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas-based epigenome editing in Alzheimer's disease.工程化的外泌体具有光诱导蛋白递药系统,可实现阿尔茨海默病基于 CRISPR-Cas 的表观基因组编辑。
Sci Transl Med. 2024 Aug 7;16(759):eadi4830. doi: 10.1126/scitranslmed.adi4830.
8
Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.使用融合向导 RNA 对 Cas9 和 Cas12a 进行基因操作。
Methods Mol Biol. 2021;2162:185-193. doi: 10.1007/978-1-0716-0687-2_10.
9
Generation and validation of a versatile inducible multiplex CRISPRi system to examine bacterial regulation in the Euprymna-Vibrio fischeri symbiosis.一种用于研究费氏弧菌与夏威夷短尾乌贼共生关系中细菌调控的通用可诱导多重CRISPR干扰系统的构建与验证
Arch Microbiol. 2025 May 17;207(7):147. doi: 10.1007/s00203-025-04354-8.
10
Investigating Murine CD4 T Cell Differentiation Using CRISPR-Cas9 Ribonucleoprotein Complex-mediated Gene Ablation.利用CRISPR-Cas9核糖核蛋白复合物介导的基因消融研究小鼠CD4 T细胞分化
J Vis Exp. 2025 Jun 20(220). doi: 10.3791/67380.

引用本文的文献

1
Cytotoxicity of activator expression in CRISPR-based transcriptional activation systems.基于CRISPR的转录激活系统中激活剂表达的细胞毒性。
Nat Commun. 2025 Aug 29;16(1):8071. doi: 10.1038/s41467-025-63570-4.
2
Programmable genome engineering and gene modifications for plant biodesign.用于植物生物设计的可编程基因组工程和基因修饰
Plant Commun. 2025 Aug 11;6(8):101427. doi: 10.1016/j.xplc.2025.101427. Epub 2025 Jun 24.
3
Three's company: Simultaneous trimodal genome engineering using orthologous Cas proteins.三人行:使用直系同源Cas蛋白进行同步三模态基因组工程。

本文引用的文献

1
Tunable translation-level CRISPR interference by dCas13 and engineered gRNA in bacteria.在细菌中通过 dCas13 和工程化的 gRNA 进行可调节的翻译水平 CRISPR 干扰。
Nat Commun. 2024 Jun 22;15(1):5319. doi: 10.1038/s41467-024-49642-x.
2
CRISPR activation to characterize splice-altering variants in easily accessible cells.CRISPR 激活技术可用于鉴定易于获取的细胞中的剪接改变变体。
Am J Hum Genet. 2024 Feb 1;111(2):309-322. doi: 10.1016/j.ajhg.2023.12.024. Epub 2024 Jan 24.
3
tgCRISPRi: efficient gene knock-down using truncated gRNAs and catalytically active Cas9.
Mol Ther. 2025 Jan 8;33(1):9-10. doi: 10.1016/j.ymthe.2024.12.022. Epub 2024 Dec 24.
tgCRISPRi:使用截断的 gRNA 和具有催化活性的 Cas9 进行高效基因敲低。
Nat Commun. 2023 Sep 11;14(1):5587. doi: 10.1038/s41467-023-40836-3.
4
CD5: from antiquated T cell marker to immunotherapy's new hope.CD5:从过时的T细胞标志物到免疫疗法的新希望。
Signal Transduct Target Ther. 2023 May 25;8(1):216. doi: 10.1038/s41392-023-01494-5.
5
Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus.用于靶向乙型肝炎病毒的APOBEC/AID基因的瞬时可调CRISPRa调控
Mol Ther Nucleic Acids. 2023 Apr 20;32:478-493. doi: 10.1016/j.omtn.2023.04.016. eCollection 2023 Jun 13.
6
CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.CRISPR-Cas 介导的转录调控:CRISPRa 和 CRISPRi 的治疗潜力。
Mol Ther. 2023 Jul 5;31(7):1920-1937. doi: 10.1016/j.ymthe.2023.03.024. Epub 2023 Mar 24.
7
Enrichment of transgene integrations by transient CRISPR activation of a silent reporter gene.通过瞬时CRISPR激活沉默报告基因来富集转基因整合。
Mol Ther Methods Clin Dev. 2023 Feb 16;29:1-16. doi: 10.1016/j.omtm.2023.02.010. eCollection 2023 Jun 8.
8
CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses.树突状细胞表达 CD5 指导 T 细胞免疫并维持免疫治疗反应。
Science. 2023 Feb 17;379(6633):eabg2752. doi: 10.1126/science.abg2752.
9
Pharmacological interventions enhance virus-free generation of -replaced CAR T cells.药理学干预可增强经基因编辑的嵌合抗原受体(CAR)T细胞无病毒生成。
Mol Ther Methods Clin Dev. 2022 Apr 12;25:311-330. doi: 10.1016/j.omtm.2022.03.018. eCollection 2022 Jun 9.
10
Impact of Manufacturing Procedures on CAR T Cell Functionality.制造工艺对 CAR T 细胞功能的影响。
Front Immunol. 2022 Apr 13;13:876339. doi: 10.3389/fimmu.2022.876339. eCollection 2022.